The GOP majority in Congress is looking to build on the Trump administration’s political and policy agenda, prioritizing tax cuts, energy reform, and border security, but tariffs could provoke a trade war that has already roiled the market and international business. Meanwhile, the administration is implementing major cuts to federal agencies — including the FDA, HHS, and NIH — and calling into question the breadth of research and development for the life sciences industry in the United States.What’s in store for businesses in the days and weeks ahead? Will the impending budget reconciliation process go smoothly? And how are tariffs impacting companies, our international trading partners, and consumers worldwide?Join The Sidley Podcast host and Sidley partner, Sam Gandhi, as he speaks with three of the firm’s thought leaders on these issues — Michael Borden, who leads Sidley’s Government Strategies practice, Pattie DeLoatche, a senior policy advisor and a member of the firm’s Government Strategies practice, and Andy Shoyer, a partner in the firm’s Global Arbitration, Trade and Advocacy practice. Together, they discuss President Trump’s tariffs, the recent cuts to federal agencies, and how businesses can best navigate the evolving landscape. Executive Producer: John Metaxas, WallStreetNorth Communications, Inc.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related